Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects

被引:55
作者
Raux, M
Finkielsztejn, L
Salmon-Céron, D
Bouchez, H
Excler, JL
Dulioust, E
Grouin, JM
Sicard, D
Blondeau, C
机构
[1] Pasteur Merieux Connaught, Clin Seroimmunol Lab, F-27101 Val Reuil, France
[2] Hop Cochin, F-75679 Paris, France
[3] Henry M Jackson Fdn, Rockville, MD USA
[4] Univ Rouen, F-76821 Mt St Aignan, France
关键词
D O I
10.1089/088922299310070
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We compared IgG and IgA distribution in serum, three different salivary samples, two different rectal secretion samples, cervicovaginal secretions, and seminal secretions from asymptomatic CDC stage II/III HIV-1-infected subjects (n = 44) and from HIV-1-seronegative volunteers (n = 52). In-house ELISAs were used to measure total IgG and total IgA levels, as well as HIV-specific anti-gp120 MN and anti-p24 LAI IgG and IgA, Human serum albumin was titrated in parallel to calculate the relative coefficient of excretion (RCE), In spite of substantial interindividual variability, total IgG concentrations in all fluids were found to be significantly greater in the HIV-1-infected group than in the seronegative subjects, Calculation of RCE values revealed three different types of mucosal secretion: secretions,vith no local Ig production, such as sperm; secretions with local production of IgA and transudative origin of IgG, such as salivary and rectal samples; and secretions with local production of both IgG and IgA, such as in cervicovaginal secretions, For all mucosal specimens from HIV-1-infected subjects, the response to HIV-1 was predominantly IgG, with highest titers observed in cervicovaginal secretions (although these were lower than serum levels). In contrast, the specific IgA response appeared weaker in the mucosa than in serum.
引用
收藏
页码:1365 / 1376
页数:12
相关论文
共 47 条
[1]  
ADA G, 1997, AIDS RES HUM RETROV, V3, P205
[2]   SECRETORY IGA ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS IN THE PAROTID-SALIVA OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX [J].
ARCHIBALD, DW ;
BARR, CE ;
TOROSIAN, JP ;
MCLANE, MF ;
ESSEX, M .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (04) :793-796
[3]   Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: A comparison by site and correlation with clinical information [J].
Artenstein, AW ;
VanCott, TC ;
Sitz, KV ;
Robb, ML ;
Wagner, KF ;
Veit, SCD ;
Rogers, AF ;
Garner, RP ;
Byron, JW ;
Burnett, PR ;
Birx, DL .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (02) :265-271
[4]  
BEHETS FM, 1991, J ACQ IMMUN DEF SYND, V4, P183
[5]   CERVICOVAGINAL OVERPRODUCTION OF SPECIFIC IGG TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) CONTRASTS WITH NORMAL OR IMPAIRED IGA LOCAL RESPONSE IN HIV-INFECTION [J].
BELEC, L ;
DUPRE, T ;
PRAZUCK, T ;
TEVIBENISSAN, C ;
KANGA, JM ;
PATHEY, O ;
LU, XS ;
PILLOT, J .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03) :691-697
[6]  
BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57
[7]   LOCAL SYNTHESIS OF IGG ANTIBODIES TO HIV WITHIN THE FEMALE AND MALE GENITAL TRACTS DURING ASYMPTOMATIC AND PRE-AIDS STAGES OF HIV-INFECTION [J].
BELEC, L ;
TEVIBENISSAN, C ;
LU, XS ;
PRAZUCK, T ;
PILLOT, J .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (06) :719-729
[8]   Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection [J].
Cartry, O ;
Moja, P ;
Quesnel, A ;
Pozzetto, B ;
Lucht, FR ;
Genin, C .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01) :47-53
[9]   COMPARISON OF 8 COMMERCIAL TEST KITS FOR DETECTING ANTI-HIV ANTIBODIES IN SALIVA SPECIMENS [J].
CHAMNANPUT, J ;
PHANUPHAK, P .
AIDS, 1993, 7 (07) :1026-1026
[10]   NOVEL ASSAY FOR THE DETECTION OF IMMUNOGLOBULIN-G ANTIHUMAN IMMUNODEFICIENCY VIRUS IN UNTREATED SALIVA AND URINE [J].
CONNELL, JA ;
PARRY, JV ;
MORTIMER, PP ;
DUNCAN, J .
JOURNAL OF MEDICAL VIROLOGY, 1993, 41 (02) :159-164